000			01096 a2200313 4500
005			20250513204330.0
264		0	_c20000419
008			200004s 0 0 fre d
022			_a0003-9683
040			_aNLM _beng _cNLM
100	1		_aFerrari, E
245	0	0	_a[The best of thrombosis and thromboembolic disease in 1999]. _h[electronic resource]
260			_bArchives des maladies du coeur et des vaisseaux _cJan 2000
300			_a77-81 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAbciximab
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aFibrinolytic Agents _xtherapeutic use
650	0	4	_aHeparin _xtherapeutic use
650	0	4	_aHirudin Therapy
650	0	4	_aHumans
650	0	4	_aImmunoglobulin Fab Fragments _xtherapeutic use
650	0	4	_aMyocardial Infarction _xetiology
650	0	4	_aPrognosis
650	0	4	_aRecurrence
650	0	4	_aThromboembolism _xdrug therapy
650	0	4	_aThrombosis _xdrug therapy
773	0		_tArchives des maladies du coeur et des vaisseaux _gvol. 93 _gno. 1 Spec No _gp. 77-81
999			_c10675281 _d10675281